NPR, April 19, 2017
Michelle Andrews


Read the Full Article

With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic now have a better chance at a cure. Kids may actually have an easier time than adults getting approved for the treatment, according to some health policy specialists. [...]

fda health care finance health law policy infectious diseases insurance pediatrics pharmaceuticals public health regulation